These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33881420)
1. Facile antibacterial materials with turbine-like structure for Tao Q; Guo L; Diao H; Feng L Biomater Sci; 2021 May; 9(10):3830-3837. PubMed ID: 33881420 [TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics. Orazi G; Ruoff KL; O'Toole GA mBio; 2019 Jul; 10(4):. PubMed ID: 31363032 [No Abstract] [Full Text] [Related]
3. Pathogen-Specific Polymeric Antimicrobials with Significant Membrane Disruption and Enhanced Photodynamic Damage To Inhibit Highly Opportunistic Bacteria. Xiao F; Cao B; Wang C; Guo X; Li M; Xing D; Hu X ACS Nano; 2019 Feb; 13(2):1511-1525. PubMed ID: 30632740 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2. Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756 [TBL] [Abstract][Full Text] [Related]
7. Facile and Novel Synthesis of Spiky Gold Nanoparticles as an Efficient Antimicrobial Agent against Pseudomonas Aeruginosa. Aziz F; Rashid M; Rehman M; Rafique M; Imran M Comb Chem High Throughput Screen; 2022; 25(7):1230-1236. PubMed ID: 34139978 [TBL] [Abstract][Full Text] [Related]
8. Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa. Lu J; Cokcetin NN; Burke CM; Turnbull L; Liu M; Carter DA; Whitchurch CB; Harry EJ Sci Rep; 2019 Dec; 9(1):18160. PubMed ID: 31796774 [TBL] [Abstract][Full Text] [Related]
9. Unnatural Amino-Acid-Based Star-Shaped Poly(l-Ornithine)s as Emerging Long-Term and Biofilm-Disrupting Antimicrobial Peptides to Treat Pseudomonas aeruginosa-Infected Burn Wounds. Pan M; Lu C; Zheng M; Zhou W; Song F; Chen W; Yao F; Liu D; Cai J Adv Healthc Mater; 2020 Oct; 9(19):e2000647. PubMed ID: 32893500 [TBL] [Abstract][Full Text] [Related]
10. A lipophilic chitosan-modified self-nanoemulsifying system influencing cellular membrane metabolism enhances antibacterial and anti-biofilm efficacy for multi-drug resistant Pseudomonas aeruginosa wound infection. Cai D; Zhang Z; Feng Z; Song J; Zeng X; Tu Y; Zhao S; Luo X; Sun C; Yang Y; Liu X; Zou Q; Zeng H; Sun H Biomater Adv; 2022 Sep; 140():213029. PubMed ID: 36058016 [TBL] [Abstract][Full Text] [Related]
11. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
12. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro. Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Activatable Phase-Shift Nanoparticle as a Targeting Antibacterial Agent for Efficient Eradication of Xin L; Zhang C; Chen J; Jiang Y; Liu Y; Jin P; Wang X; Wang G; Huang P ACS Appl Mater Interfaces; 2022 Oct; 14(42):47420-47431. PubMed ID: 36222290 [TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms. Orazi G; Jean-Pierre F; O'Toole GA J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077 [TBL] [Abstract][Full Text] [Related]
15. Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity. Pestrak MJ; Baker P; Dellos-Nolan S; Hill PJ; Passos da Silva D; Silver H; Lacdao I; Raju D; Parsek MR; Wozniak DJ; Howell PL Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30988141 [No Abstract] [Full Text] [Related]
16. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms. Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746 [No Abstract] [Full Text] [Related]
17. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117 [TBL] [Abstract][Full Text] [Related]